-
COST-EFFECTIVENESS OF CT1 FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) TREATMENT ALLOCATION IN THE UNITED KINGDOM
Mar 18, 2026, 21:38 PM -
DYNAMIC VALUATION FRAMEWORKS FOR BUDGET IMPACT AND COST-EFFECTIVENESS MODELLING USING THE DYNAMICPV PACKAGE FOR R
Mar 18, 2026, 21:38 PM -
MOST-FAVOURED NATION, LEAST-FAVOURED CONSEQUENCES: GLOBAL RIPPLE EFFECTS OF U.S. PRICING POLICY
Mar 18, 2026, 21:38 PM -
A HEALTH ECONOMIC AND ENVIRONMENTAL EVALUATION OF SUBCUTANEOUS PERTUZUMAB/TRASTUZUMABVERSUS INTRAVENOUS PERTUZUMAB/TRASTUZUMAB FOR HER2-POSITIVE BREAST CANCER IN DENMARK (HEREAFTER)
Mar 18, 2026, 21:38 PM -
TRENDS IN PCSK9 INHIBITOR COSTS, COST SHARING, AND ADHERENCE AMONG MEDICARE BENEFICIARIES FOLLOWING 2018 PRICE REDUCTIONS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF AN INTEGRATED TEST TO ACCELERATE THE TRIPLE ELIMINATION OF HIV, SYPHILIS AND HEPATITIS B IN NIGERIA
Mar 18, 2026, 21:38 PM -
ADHERENCE TO MULTI-TARGET STOOL DNA TESTING FOR COLORECTAL CANCER SCREENING IN A NORTHEASTERN U.S. CORRECTIONAL FACILITY
Mar 18, 2026, 21:38 PM -
ENHANCING CLINICAL TRIAL ELIGIBILITY CRITERIA DESIGN WITH GENERATIVE ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
Mar 18, 2026, 21:38 PM -
SOCIAL MEDIA CONVERSATIONS ON GLP-1 THERAPIES FOR OBESITY: REAL-WORLD EXPERIENCES AND TREATMENT NARRATIVES
Mar 18, 2026, 21:38 PM -
INDIRECT ECONOMIC BURDEN OF ADULT OVERWEIGHT AND OBESITY: A SYSTEMATIC REVIEW TO INFORM POLICY AND ECONOMIC MODELING IN COLOMBIA
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING SLEEVE GASTRECTOMY: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
PSYCHOSOCIAL AND SUPPORTIVE INTERVENTIONS FOR CAREGIVERS OF INDIVIDUALS WITH DEMENTIA: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
NOVEL PATIENT-CENTERED APPROACH TO CLINICAL TRIAL READINESS IN RARE DISEASES
Mar 18, 2026, 21:38 PM -
GEOGRAPHIC AND TEMPORAL TRENDS IN ADULT DIABETES PREVALENCE, UNITED STATES, 2011-2021
Mar 18, 2026, 21:38 PM -
REAL-WORLD CHARACTERISTICS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB IN SWEDEN: THE BIMENORDIX STUDY
Mar 18, 2026, 21:38 PM -
INCIDENCE AND COSTS OF SECONDARY STROKE EVENTS IN PATIENTS WITH ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK OF NON-CARDIOEMBOLIC ORIGIN
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF INAVOLISIB IN THE TREATMENT OF PIK3A-MUTATED, HR+/HER2-ABC LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN THE US
Mar 18, 2026, 21:38 PM -
PSYCHOSOCIAL CORRELATES OF HEALTH ANXIETY IN A HEALTHY ADULT POPULATION
Mar 18, 2026, 21:38 PM -
INCLUSION OF PATIENT-REPORTED OUTCOME MEASURES FOR PEDIATRIC VERSUS ADULT POPULATIONS IN FDA BIOLOGICAL AND NOVEL DRUG THERAPY APPROVALS FROM 2021-2025
Mar 18, 2026, 21:38 PM -
A LANDSCAPE ASSESSMENT OF THE STATISTICAL AND ECONOMIC MODELING OF CURE IN ONCOLOGY
Mar 18, 2026, 21:38 PM
